Our client, a top pharmaceutical company in the United States, was interested in improving the reach and impact of their medical content. We developed an analytical study to help them globalize their reach and improve performance associated with the content itself. We describe our case study here.

Download

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now